Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Pump's daily trading recs, emphasis on short selling -- Ignore unavailable to you. Want to Upgrade?

To: Michail Shadkin who wrote (4162)	7/18/2001 2:14:56 AM
From: double-plus-good	Respond to of 6873

Michail; I suppose I could concede that the chart is bullish, though it appears to be forming a blowoff in its vertical ascent. PRX is in the hot money generic pharm craze currently in progress; aka WFHC, TARO and more. The lone estimate is from a third or fourth tier firm and is based on conjecture at best. The CEO and two VP's recently sold their entire stakes according to filings... so I tend to think this is a bit of mania in action. Even if all the bullish conjecture takes place the exclsivity period for generic ANDA approvals is usually 180 days. So even if they earn 1-2 bucks in 2002 they could very well be back to 40-50 cents the next year. I think the sector will be in for some unwinding, though your observations suggest it may be best to wait for the craze to die down a bit. thanks for your input ++